{"id":"W2416661311","doi":"10.1177/135965350501000119","title":"Challenges for the Clinical Development of New Nucleoside Reverse Transcriptase Inhibitors for HIV Infection","year":2005,"lang":"en","type":"article","venue":"Antiviral Therapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Paul's Hospital; McGill University; Jewish General Hospital","funders":"","keywords":"Tolerability; Clinical trial; Drug resistance; Nucleoside Reverse Transcriptase Inhibitor; Reverse transcriptase; Drug development; Clinical study design; Medicine; Pharmacodynamics; Pharmacology; Reverse-transcriptase inhibitor; Intensive care medicine; Biology; Drug; Human immunodeficiency virus (HIV); Bioinformatics; Pharmacokinetics; Virology; Antiretroviral therapy; Viral load; Adverse effect; Genetics; RNA","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005074235,0.000167143,0.0003137349,0.00006118303,0.0001202889,0.000007496494,0.00005938091,0.00009134458,0.00002214069],"category_scores_gemma":[0.00003238699,0.0001051139,0.0002666517,0.00007329424,0.00005002764,0.00008945834,0.000007021413,0.00007999904,0.00001952422],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003884594,"about_ca_system_score_gemma":0.0002080018,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005640105,"about_ca_topic_score_gemma":0.00005957838,"domain_scores_codex":[0.998909,0.00002745253,0.0004775906,0.0002344124,0.0001443399,0.0002071942],"domain_scores_gemma":[0.9993978,0.0001820896,0.000111095,0.0001763642,0.00006819396,0.00006445729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001147129,0.0005549681,0.01009545,0.00003994677,0.0004361196,9.034492e-7,0.003205545,6.778523e-7,0.001505574,0.00021284,0.02604888,0.9567519],"study_design_scores_gemma":[0.007387212,0.0003581461,0.02824889,0.0000877754,0.00009676856,0.000002197534,0.0001773073,0.00005044978,0.05799216,0.00008818261,0.9053726,0.0001383395],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9416032,0.004147348,0.006196114,0.0432763,0.0005670795,0.003380524,0.00001495348,0.00009952464,0.0007149688],"genre_scores_gemma":[0.9464714,0.008812591,0.034548,0.0005993014,0.0008716859,0.0001987004,0.00005298604,0.00004612374,0.008399236],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9566136,"threshold_uncertainty_score":0.428642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1290066153084961,"score_gpt":0.3734704503012295,"score_spread":0.2444638349927334,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}